HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IRTC
iRhythm Technologies, Inc.
IRTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IRTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Unavailable |
IRTC's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IRTC PE Valuation
IRTC has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 100x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IRTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IRTC has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IRTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.94 | — |
| Q3 2026 | -$1.16 | +$0.44 |
| Q2 2026 | -$0.42 | +$2.50 |
| Q1 2026 | -$0.85 | +$2.28 |
| Q4 2025 | -$1.39 | +$2.24 |
| Q3 2025 | -$1.60 | +$3.25 |
| Q2 2025 | -$2.92 | +$1.34 |
| Q1 2025 | -$3.13 | +$1.09 |
| Q4 2024 | -$3.63 | +$0.41 |
IRTC has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over IRTC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over IRTC on profitability, with a higher operating margin.
IRTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $221.6M | +15% |
| Q2 2026 | $224.2M | +20% |
| Q1 2026 | $199.4M | +26% |
| Q4 2025 | $208.9M | +27% |
| Q3 2025 | $192.9M | +31% |
| Q2 2025 | $186.7M | +26% |
| Q1 2025 | $158.7M | +20% |
| Q4 2024 | $164.3M | +24% |
IRTC's revenue has grown year over year every quarter since late 2020: $222M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -10 points |
| Q2 2026 | -1.1% | +8.9 points |
| Q1 2026 | -8.1% | +12 points |
| Q4 2025 | 1.1% | +3.6 points |
| Q3 2025 | -4.4% | +30 points |
| Q2 2025 | -10% | +5.5 points |
| Q1 2025 | -21% | +8.4 points |
| Q4 2024 | -2.5% | +27 points |
IRTC's operating margin was −15% last quarter, down 10 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over IRTC on cash flow, with more consistent year-over-year improvement.
IRTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.5M | -158% |
| Q2 2026 | $37.5M | +117% |
| Q1 2026 | -$33.1M | -$15.8M |
| Q4 2025 | $14.5M | +17% |
| Q3 2025 | $20.1M | +29% |
| Q2 2025 | $17.3M | +416% |
| Q1 2025 | -$17.3M | +$44.5M |
| Q4 2024 | $12.4M | +$41.9M |
IRTC has burned cash in most quarters: $7M over the past year, down 77% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over IRTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
IRTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +204K shares |
| 1 year | +2.9% | +929K shares |
| 3 years | +8.1% | +2.5M shares |
| 5 years | +13% | +3.7M shares |
| Available history | +31% | +7.8M shares |
IRTC has 33M diluted shares, up 2.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $25M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IRTC Net Leverage
IRTC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IRTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.6 | Neutral |
| Stochastic | 29.9 | Neutral |
IRTC's weekly RSI is 38 (neutral) and its Stochastic is 30 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
IRTC PE vs Healthcare Sector
IRTC has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IRTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $108.1 | 13% below |
| 20 week MA | $114.6 | 18% below |
| 50 week MA | $127.7 | 27% below |
| 100 week MA | $133.3 | 30% below |
| 200 week MA | $116.0 | 19% below |
IRTC is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over IRTC on returns for 2026, with the stronger performance.
IRTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66.1 | $242.1 | +266% |
| 2021 | $242.1 | $118.8 | -51% |
| 2022 | $118.8 | $95.2 | -20% |
| 2023 | $95.2 | $107.0 | +12% |
| 2024 | $107.0 | $88.8 | -17% |
| 2025 | $88.8 | $176.6 | +99% |
| 2026 YTD | $176.6 | $93.6 | -47% |
IRTC's yearly returns have swung widely, from +266% in 2020 to −51% in 2021. It's down 47% so far in 2026.